Insider filing · BHC

John Paulson bought $312.5M of Bausch Health Companies (BHC)

Executed Aug 14 2025, disclosed Aug 15 2025, the same day.

Over the 21 trading sessions from the disclosed entry session (Aug 14 2025), the stock returned -1.2% (delay-adjusted); from the execution session (Aug 14 2025), -1.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

JP John Paulson Director profile →

John Paulson (Director) filed 4 Form 4 reports in the past 24 months (4 purchases, 0 sales), most often in Bausch Health Companies Inc. (BHC). Across 4 priced purchase filings, the average 21-session return was +17.6% from execution and +8.1% from disclosure (delay-adjusted; derived). The largest single filing was $312.5M of BHC (34,721,118 sh × $9.00, as filed), executed Aug 14 2025.

BHC Bausch Health Companies Inc. BHC · Healthcare · 8 filings in 24 months ticker →

Healthcare · Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→